| BNUEX | VGTSX | BNUEX / VGTSX | |
| Total Expense Ratio | 1.00 | 0.17 | 588% |
| Annual Report Gross Expense Ratio | 1.24 | 0.17 | 729% |
| Fund Existence | 32 years | 30 years | - |
| Gain YTD | 27.500 | 29.336 | 94% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2000000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 158M | 558B | 0% |
| Annual Yield % from dividends | 1.31 | 2.63 | 50% |
| Returns for 1 year | 21.54 | 22.99 | 94% |
| Returns for 3 years | 32.67 | 46.92 | 70% |
| Returns for 5 years | 9.35 | 33.28 | 28% |
| Returns for 10 years | 50.71 | 84.71 | 60% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SBHIX | 25.52 | 0.24 | +0.95% |
| Saratoga Health & Biotechnology I | |||
| TASZX | 21.33 | 0.17 | +0.80% |
| Third Avenue Small Cap Value Z | |||
| ETAHX | 50.88 | 0.17 | +0.34% |
| Eventide Healthcare & Life Sciences A | |||
| JFCAX | 39.58 | 0.08 | +0.20% |
| JHancock Fundamental All Cap Core A | |||
| OEGAX | 28.06 | -2.23 | -7.36% |
| Invesco Discovery Mid Cap Growth A | |||